发明授权
US07888349B2 Piperazine, [1,4]Diazepane, [1,4]Diazocane, and [1,5]Diazocane fused imidazo ring compounds
失效
哌嗪,[1,4]二氮杂环庚烷,[1,4]二氮杂环辛烷和[1,5]二氮辛烷稠合咪唑环化合物
- 专利标题: Piperazine, [1,4]Diazepane, [1,4]Diazocane, and [1,5]Diazocane fused imidazo ring compounds
- 专利标题(中): 哌嗪,[1,4]二氮杂环庚烷,[1,4]二氮杂环辛烷和[1,5]二氮辛烷稠合咪唑环化合物
-
申请号: US10596895申请日: 2004-12-22
-
公开(公告)号: US07888349B2公开(公告)日: 2011-02-15
- 发明人: Tushar A. Kshirsagar , George W. Griesgraber , Azim A. Celebi , Philip D. Heppner
- 申请人: Tushar A. Kshirsagar , George W. Griesgraber , Azim A. Celebi , Philip D. Heppner
- 申请人地址: US MN St. Paul
- 专利权人: 3M Innovative Properties Company
- 当前专利权人: 3M Innovative Properties Company
- 当前专利权人地址: US MN St. Paul
- 国际申请: PCT/US2004/043474 WO 20041222
- 国际公布: WO2005/066172 WO 20050721
- 主分类号: A61K31/55
- IPC分类号: A61K31/55 ; C07D243/14 ; C07D487/22 ; A01N43/62
摘要:
Piperazine, [1,4]diazepane, [1,4]diazocane, and [1,5]diazocane fused imidazo ring compounds (i.e., imidazoquinolines, tetrahydroimidazoquinolines, imidazonaphthyridines, tetrahydroimidazonaphthyridines, and imidazopyridines), pharmaceutical compositions containing the compounds, intermediates, methods of making, and methods of use of these compounds as immunomodulators, for inducing or inhibiting cytokine biosynthesis in animals and in the treatment of diseases including viral and neoplastic diseases are disclosed.
公开/授权文献
信息查询